These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30270090)

  • 1. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia.
    Hagger MS; Hardcastle SJ; Hu M; Kwok S; Lin J; Nawawi HM; Pang J; Santos RD; Soran H; Su TC; Tomlinson B; Watts GF
    Atherosclerosis; 2018 Oct; 277():493-501. PubMed ID: 30270090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting intention to participate in self-management behaviors in patients with Familial Hypercholesterolemia: A cross-national study.
    Hagger MS; Hamilton K; Hardcastle SJ; Hu M; Kwok S; Lin J; Nawawi HM; Pang J; Santos RD; Soran H; Su TC; Tomlinson B; Watts GF
    Soc Sci Med; 2019 Dec; 242():112591. PubMed ID: 31630009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Self-Management Behaviors in Familial Hypercholesterolemia Using an Integrated Theoretical Model: the Impact of Beliefs About Illnesses and Beliefs About Behaviors.
    Hagger MS; Hardcastle SJ; Hingley C; Strickland E; Pang J; Watts GF
    Int J Behav Med; 2016 Jun; 23(3):282-294. PubMed ID: 26742538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and first results of a health-related outcomes set in familial hypercholesterolemia (FH) patients: Knowledge is health.
    Mulder JWCM; Galema-Boers AMH; de Jong-Verweij LM; Hazelzet JA; Roeters van Lennep JE
    Atherosclerosis; 2020 Jan; 293():11-17. PubMed ID: 31821958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latvian registry of familial hypercholesterolemia: The first report of three-year results.
    Latkovskis G; Saripo V; Gilis D; Nesterovics G; Upena-Roze A; Erglis A
    Atherosclerosis; 2018 Oct; 277():347-354. PubMed ID: 30270070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions.
    Senior V; Marteau TM; Weinman J;
    Cardiovasc Drugs Ther; 2004 Nov; 18(6):475-81. PubMed ID: 15770435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry.
    Vrablik M; Raslová K; Vohnout B; Blaha V; Satny M; Kyselak O; Vaclova M; Urbanek R; Maskova J; Soska V; Freiberger T
    Atherosclerosis; 2018 Oct; 277():355-361. PubMed ID: 30270071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice.
    Vohnout B; Fábryová Ľ; Klabník A; Kadurová M; Bálinth K; Kozárová M; Bugáňová I; Sirotiaková J; Rašlová K
    Atherosclerosis; 2018 Oct; 277():323-326. PubMed ID: 30270066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness, treatment rates, and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable, or definite familial hypercholesterolemia.
    Yaman S; Ozdemir D; Akman BT; Cakir B; Ersoy O
    Postgrad Med; 2021 Mar; 133(2):146-153. PubMed ID: 32744105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
    Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.
    Schmidt N; Dressel A; Grammer TB; Gouni-Berthold I; Julius U; Kassner U; Klose G; König C; Koenig W; Otte B; Parhofer KG; Reinhard W; Schatz U; Schunkert H; Steinhagen-Thiessen E; Vogt A; Laufs U; März W
    Atherosclerosis; 2018 Oct; 277():314-322. PubMed ID: 30270065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil.
    Souto AC; Miname MH; Fukushima J; Jannes CE; Krieger JE; Hagger M; Pereira AC; Santos RD
    Atherosclerosis; 2018 Oct; 277():464-469. PubMed ID: 30270086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C.
    van Delden XM; Huijgen R; Wolmarans KH; Brice BC; Barron JK; Blom DJ; Marais AD
    Atherosclerosis; 2018 Oct; 277():327-333. PubMed ID: 30270067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social cognition correlates of self-management behaviors in patients with familial hypercholesterolemia (FH): A meta-analytic review.
    Majeed R; Hamilton K; Watts GF; Hagger MS
    Soc Sci Med; 2024 Jun; 351():116968. PubMed ID: 38759387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis.
    Leipold R; Raal F; Ishak J; Hovingh K; Phillips H
    Eur J Prev Cardiol; 2017 Nov; 24(17):1843-1850. PubMed ID: 28925748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolemia treatments: Guidelines and new therapies.
    Raal FJ; Hovingh GK; Catapano AL
    Atherosclerosis; 2018 Oct; 277():483-492. PubMed ID: 30270089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes, norms, and self-efficacy: a model of adolescents' HIV-related sexual risk behavior.
    Basen-Engquist K; Parcel GS
    Health Educ Q; 1992; 19(2):263-77. PubMed ID: 1618632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry.
    Brunham LR; Ruel I; Khoury E; Hegele RA; Couture P; Bergeron J; Baass A; Dufour R; Francis GA; Cermakova L; Mancini GBJ; Brophy JM; Brisson D; Gaudet D; Genest J
    Atherosclerosis; 2018 Oct; 277():419-424. PubMed ID: 30270080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.